Latest News
13-Nov-2024 Pharma Market Sees 6.1% Growth in Oct Despite Subdued Volumes
08-Nov-2024 Biocon Biologics Looking to Pare $300m Acquisition Debt
07-Nov-2024 NPPA asks Cos to Cut Prices of 3 Cancer Drugs Post Tax Relief
06-Nov-2024 Health Groups Raise Concerns over Patents for Rare Disease Drugs
05-Nov-2024 CDSCO may Regulate Health Supplements to Stem Unapproved Claims by Firms
  more...
Latest Reports
Oct-24 Steady Q2; Revlimid to normalise - HDFC Securities  
Oct-24 Q2FY25 preview: Seasonality to boost volumes - ICICI Securities  
Oct-24 Domestic Formulations Strengthen Amid U.S. Generics... - Sharekhan  
Oct-24 Healthy quarter in the offing - Emkay Research  
Oct-24 Strong quarter aided by US sales & higher margins - Prabhudas Lilladher  
  more...

Quarterly Summary September-2024
Desc Current Previous Per.Chg
Sales 23254.9 21963.1 5.9
Otherincome 829.8 707.4 17.3
Expense 17835.1 16977.8 5.0
RawMaterial 6505.9 6625.9 -1.8
StaffCost 3513.9 3238.1 8.5
ExciseDuty 0.0 0.0 -100.0
OtherExp 5908.1 5608.5 5.3
Interest 571.5 465.2 22.9
GrossProfit 6559.7 5857.3 12.0
Depreciation 1115.1 1216.4 -8.3
Tax 1259.0 1017.7 23.7
NetProfit 4190.2 3702.0 13.2
Total.Comp 49 -- --
Source: ETIG Database

Sectoral Companies As on 14 Nov 2024
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 424340.20
Divi's Lab 152483.77
Cipla 121144.61
Torrent Phar 104995.93
Mankind Phar 104396.36
Dr.Reddy's 102301.61
Zydus Life 96398.99
Lupin 91845.80
Aurobindo Ph 73137.90
Alkem Labora 66023.88
Abbott (I) 58112.38
Glenmark Pha 43224.57
GlaxoSmith.P 41618.95
  click here for the complete list